A Multicenter, Open-Label, Single-Arm Extension Study to Evaluate the Safety and Efficacy of FURESTEM-OA-Kit Inj. in Knee Osteoarthritis Patients Who Received Placebo in the K0701 Phase 2a Trial

ConditionKnee Osteoarthritis

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age19+

SponsorKang Stem Biotech Co., Ltd.

About this trial

A Multicenter, Open-Label, Single-Arm Extension Study to Evaluate the Safety and Efficacy of FURESTEM-OA-Kit Inj. in Knee Osteoarthritis Patients Who Received Placebo in the K0701 Phase 2a Trial

Eligibility criteria

Qualifiers

Participants who received placebo in the K0701 clinical trial and completed the Long-term follow-up study

Participants who voluntarily provide written informed consent to participate in this extension study

Disqualifiers

Participants whom the investigator considers unsuitable for participation in this extension study.

Pregnant or breastfeeding women, and women of childbearing potential or men who do not agree to use an appropriate method of contraception during the study

Trial design

Treatments tested in this trial

Not listed

Trial groups

No trial groups listed

Sponsors and collaborators

Kang Stem Biotech Co., Ltd.

Lead sponsor

Source ClinicalTrials.gov